Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
TRIM37
REST API REST API
Homo sapiens
TRIM37 is differentially expressed in 287 experiments: 139 organism parts: bone marrow, lung, ... (137 more);, 143 disease states: normal, acute myeloid leukemia, ... (141 more);, 83 cell types 329 cell lines 38 compound treatments and 70 other conditions.
Synonyms POB1, TEF3, MUL, KIAA0898
Orthologs Trim37 (Mus musculus)   TRIM37 (Gallus gallus)   TRIM37 (Bos taurus)   ENSCING00000014869 (Ciona intestinalis)   Q1RQ14_CIOIN (Ciona intestinalis)   ENSCING00000014871 (Ciona intestinalis)   TRIM37 (Danio rerio)   Trim37 (Rattus norvegicus)   trim37 (Xenopus laevis)   TRIM37 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term ligase activity, protein binding, cytoplasm, intracellular, metal ion binding, peroxisome, perinuclear region of cytoplasm, zinc ion binding
InterPro Term MATH, Bbox_C, Znf_RING, Znf_B-box
Gene-Disease Assocation MULIBREY NANISM
UniProt Accession O94972, A8K0V9, B3KMU3, F8WEE6
Search EB-eye ENSG00000108395
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-15765, E-GEOD-803, E-GEOD-6573, E-GEOD-2549, E-GEOD-3526, ... (27 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-5258, E-MEXP-1006, E-GEOD-19639, E-GEOD-18005, ... (36 experiments)

Factor Value U/D Experiments
BT474
3
E-MTAB-37, E-MEXP-440, E-MTAB-62
MCF-7
3
E-GEOD-19639, E-GEOD-3529, E-GEOD-20081
A549
2
E-GEOD-3202, E-GEOD-6013
MCF7
2
E-GEOD-5258, E-MTAB-37
PC3
2
E-GEOD-5258, E-MEXP-2034
T84
2
E-MTAB-37, E-GEOD-1474
323 more value(s).


Cell type

studied in E-GEOD-21668, E-GEOD-3920, E-GEOD-4219, E-GEOD-13909, E-GEOD-20677, ... (46 experiments)

Factor Value U/D Experiments
CXCR4 positive
1
E-GEOD-15893
partially reprogrammed human induced pluripotent stem cell
1
E-GEOD-18265
T-cell
1
E-GEOD-10820
astrocyte
1
E-GEOD-4483
keratinocyte
1
E-GEOD-3204
macrophage
1
E-GEOD-3982
77 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-15960, E-MEXP-2280, E-MTAB-62, E-MTAB-680, ... (57 experiments)

Factor Value U/D Experiments
myeloma
2
E-MTAB-372, E-MTAB-62
acute lymphoblastic leukemia
2
E-MTAB-37, E-MTAB-62
Decidualised
1
E-MTAB-680
gastric carcinoma
1
E-GEOD-15460
CLL (Chronic Lymphocytic Leukemia)
1
1
E-GEOD-16455
medulloblastoma
1
E-MTAB-37
137 more value(s).


Compound treatment

studied in E-GEOD-5741, E-GEOD-1417, E-GEOD-15205, E-GEOD-5824, E-GEOD-5099, ... (24 experiments)

Factor Value U/D Experiments
none
3
5
E-GEOD-5824, E-GEOD-2803, E-MEXP-1601, E-GEOD-412, E-MEXP-1269, ... (8 experiments)
17beta-estradiol
3
1
E-GEOD-4006
hydrogen peroxide
1
E-GEOD-5339
hydroxyurea
1
E-GEOD-6431
camptothecin
1
E-GEOD-1417
unknown
1
E-GEOD-7307
32 more value(s).


Age at diagnosis

studied in E-GEOD-3494

Factor Value U/D Experiments
50
1
1
E-GEOD-3494


Age at onset
studied in E-GEOD-21521

Agent
studied in E-GEOD-19519

Biopsy tissue
studied in E-GEOD-5851

BioSourceProvider
studied in E-GEOD-19466, E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

Cellular component
studied in E-GEOD-1400

Clinical history
studied in E-GEOD-22097, E-TABM-234, E-GEOD-19743, E-GEOD-7967, E-GEOD-21374, ... (9 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-6710, E-GEOD-19348, E-GEOD-1140, ... (10 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

development stage
studied in E-GEOD-22601

Developmental stage
studied in E-GEOD-19743, E-GEOD-1614, E-GEOD-20033, E-MEXP-2359, E-GEOD-2666, ... (7 experiments)

Disease staging
studied in E-GEOD-19743, E-MEXP-2280, E-TABM-147, E-GEOD-21138, E-GEOD-1751, ... (6 experiments)

double amplification
studied in E-GEOD-22601

Environmental stress
studied in E-GEOD-1643

Er
studied in E-GEOD-20194, E-GEOD-16716

Er ihc
studied in E-GEOD-21653

Estrogen receptor status
studied in E-GEOD-6532, E-GEOD-20194, E-GEOD-16716

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

family id
studied in E-GEOD-19519

Family relationship
studied in E-MEXP-1425

Genetic modification
studied in E-MEXP-1482, E-GEOD-7578, E-GEOD-20847, E-MEXP-2340, E-MEXP-563 ... (5 experiments)

Genotype
studied in E-TABM-1029, E-GEOD-17476, E-GEOD-22593, E-GEOD-18005, E-TABM-601, ... (8 experiments)

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-GEOD-13073, E-MEXP-1220, E-GEOD-6432, E-GEOD-7011, E-MEXP-2657, ... (12 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-TABM-276

Individual
studied in E-TABM-325, E-MTAB-197, E-MEXP-2069, E-GEOD-1926, E-GEOD-16363, ... (35 experiments)

Infection
studied in E-GEOD-12108, E-GEOD-9723, E-MEXP-561, E-GEOD-980

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-7214

Ki67 ihc
studied in E-GEOD-21653

Light
studied in E-GEOD-1725

Material type
studied in E-MEXP-455

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Observation
studied in E-TABM-276

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-7540, E-GEOD-1801, E-AFMX-1, E-GEOD-426, E-TABM-84 ... (5 experiments)

Organism status
studied in E-GEOD-19188

Phase
studied in E-GEOD-4888

Phenotype
studied in E-GEOD-19703, E-GEOD-1493, E-GEOD-22309, E-GEOD-21750, E-GEOD-17636 ... (5 experiments)

Population
studied in E-GEOD-4922

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-22097, E-GEOD-3254, E-GEOD-21837, E-GEOD-19445, E-GEOD-19246 ... (5 experiments)

RNAi
studied in E-MEXP-2115, E-GEOD-12438, E-MEXP-1509, E-MEXP-101, E-MEXP-1857, ... (6 experiments)

Sample preparation
studied in E-GEOD-16728, E-GEOD-12710

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-GEOD-17400

Sex
studied in E-GEOD-1643, E-GEOD-2466, E-GEOD-7307

Stimulation
studied in E-GEOD-11886, E-GEOD-11428

stimulus
studied in E-GEOD-22103

Strain or line
studied in E-MEXP-1996

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

Test result
studied in E-GEOD-1926, E-TABM-276, E-GEOD-2748

Treatment
studied in E-GEOD-16837, E-GEOD-19246, E-GEOD-13818, E-GEOD-19815, E-GEOD-12198 ... (5 experiments)

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-4290, E-GEOD-1561, E-GEOD-6532, E-GEOD-4922, E-TABM-147 ... (5 experiments)

Vehicle
studied in E-GEOD-5258

Processing time: 0.269 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM